Monitoring of Hearing Screening in Newborn

An undiagnosed hearing loss may have effect significantly child's and parents quality of life. Congenital hearing loss is one of the most common neurologic congenital problem in the world. For healty newborn, hearing loss rate is 1-3/1000 for all over the world and 2,2/1000 in our country, but on the other hand for neonatal intensive care, this rate is 1-6/100. Otoacustic emission (OAE) testing and/or auditory brainstem response (ABR) testing is used for neonatal hearing screening program. While OAE testing informs about peripheral auditory system extending to the coclear outer hairy cells, ABR testing shows the status of the peripheral auditory system, eighth nerve and the brainstem. Early diagnosis and management of hearing loss in children is very important. By hearing tests should be performed in the first month of life and appropriate rehabilitation programs should be started in the first six months